MeiraGTx Holdings plc
MGTXNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $926.80M
- P/E (TTM)
- 11.73
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $6.62$15.35
- Volume (live)
- -
- Avg. volume (3M)
- 978.27K
MeiraGTx Holdings (MGTX) Stock Price & Financial Analysis
MeiraGTx Holdings Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $9.25 - $9.89 |
|---|---|
| 52-Week High | $15.35 |
| 52-Week Low | $6.62 |
| Open | $9.89 |
| Volume (last close) | 666.43K |
| Average Volume (3M) | 978.27K |
| Revenue (TTM) | 397.50M |
|---|---|
| Net Income (TTM) | 78.98M |
| Free Cash Flow (TTM) | 6.31M |
| EPS (TTM) | $0.94 |
| Profit Margin | 19.87% |
| Operating Margin | 46.30% |
| Return on Equity (ROE) | 36.64% |
| Debt to Equity | 0.52 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 926.80M |
|---|---|
| Shares Outstanding | 93.81M |
| P/E Ratio (TTM) | 11.73 |
| Price to Sales (P/S) | 2.33 |
| Price to Book (P/B) | 4.30 |
| EV/EBITDA | 3.45 |
| 50-Day MA | $12.63 |
|---|---|
| 200-Day MA | $10.19 |
| 1-Year Change | +27.48% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
MeiraGTx Holdings at a Glance
As of the Oct 16, 2026 close, MeiraGTx Holdings (MGTX) has a market capitalization of $926.80M. The stock trades at 11.7× trailing earnings and 2.3× sales. Over the trailing twelve months it earned $78.98M on revenue of $397.50M (a 19.9% profit margin) and generated $6.31M of free cash flow. Revenue grew 948.4% year over year.
As of its latest reported balance sheet, it holds $143.17M in cash and securities against $112.32M of debt, a net cash position of $30.84M.
MeiraGTx Holdings does not currently pay a dividend.
The share price is up 27.5% over the past year. At $9.28 (the Oct 16, 2026 close) it sits within its 52-week range of $6.62 to $15.35, below its 200-day moving average of $10.19.
Based on 7 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $22.40, 141.4% above the Oct 16, 2026 close.
Frequently Asked Questions About MeiraGTx Holdings
What is the current stock price for MGTX?
As of the Oct 16, 2026 close, MGTX stock trades at $9.28. The 52-week range is $6.62–$15.35, with a day range of $9.25–$9.89.
What is the P/E ratio for MGTX?
As of the Oct 16, 2026 close, MeiraGTx Holdings's trailing twelve-month (TTM) P/E ratio is 11.7, meaning investors pay $11.7 for every $1 of annual earnings. MeiraGTx Holdings operates in the Healthcare sector.
Does MGTX pay dividends?
MeiraGTx Holdings does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for MGTX?
Based on ratings from 7 professional analysts over the last 90 days, the consensus for MGTX is Buy. The average 12-month price target is $22.40, a 141.4% upside from the Oct 16, 2026 close of $9.28.
What is the market cap of MGTX?
As of the Oct 16, 2026 close, MeiraGTx Holdings's market capitalization is $870.5M, classifying it as a small-cap company. MeiraGTx Holdings operates in the Healthcare sector within the Biotechnology industry.